Mode
Text Size
Log in / Sign up
N/A N=188

Tailored Motivational Interviewing Implementation-Effectiveness Trial in Multidisciplinary Adolescent HIV Care Settings

HIV Infections · Adolescent Development · Care Eliciting Behavior · Patient Non-Compliance · Patient Refusal of Treatment

Enrolled (actual)
188
Serious AEs
Results posted
Jan 2025
Primary outcome: Primary: Raw Average: 12-Item Motivational Interviewing (MI) Coach Rating Scale (CRS) — 2.72; 2.50; 1.99; 2.32 Units on a scale

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Competency: 12-Item Motivational Interviewing (MI) Coach Rating Scale (CRS) (Behavioral); Randomized Guided Development of COPs with an internal facilitator after one year of implementation. (Behavioral); CoP development without internal facilitation. (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Florida State University
Primary completion
Dec 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Raw Average: 12-Item Motivational Interviewing (MI) Coach Rating Scale (CRS)
2.72; 2.50; 1.99; 2.32; 2.47; 2.91
SECONDARY
Change in Individual Patients' Records Report Related to HIV Viral Load
1.88; 2.43; 2.29; 2.28; 2.30; 2.20

Summary

The goal of this study is to test a multi-faceted Tailored Motivational Interviewing Implementation intervention (TMI), based on the Dynamic Adaptation Process (DAP) to scale up an Evidence-based Practice (EBP) in multidisciplinary adolescent HIV care settings while balancing flexibility and fidelity. A mixed-methods design will be used, in which the dominant method is quantitative (a dynamic wait-listed design; DWLD) to determine the impact of TMI on the integration of MI with fidelity in 10 adolescent HIV clinics with an average of 15 providers and 100 patients each.

Eligibility Criteria

Inclusion Criteria

  • All youth HIV providers (prevention and care) at our target clinics will be eligible to participate.

Exclusion Criteria

  • Non-providers of youth HIV prevention and care
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03681912). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search